Clinical Reviews in Allergy & Immunology

, Volume 49, Issue 3, pp 278–287 | Cite as

The Differential Diagnosis of Dry Eyes, Dry Mouth, and Parotidomegaly: A Comprehensive Review

  • Divi Cornec
  • Alain Saraux
  • Sandrine Jousse-Joulin
  • Jacques-Olivier Pers
  • Sylvie Boisramé-Gastrin
  • Yves Renaudineau
  • Yves Gauvin
  • Anne-Marie Roguedas-Contios
  • Steeve Genestet
  • Myriam Chastaing
  • Béatrice Cochener
  • Valérie Devauchelle-Pensec
Article

Abstract

Primary Sjögren’s syndrome (pSS) is a frequent autoimmune systemic disease, clinically characterized by eyes and mouth dryness in all patients, salivary gland swelling or extraglandular systemic manifestations in half of the patients, and development of lymphoma in 5 to 10 % of the patients. However, patients presenting with sicca symptoms or salivary gland swelling may have a variety of conditions that may require very different investigations, treatments, or follow-up. Eye and/or mouth dryness is a frequent complaint in clinical setting, and its frequency increases with age. When evaluating a patient with suspected pSS, the first step is to rule out its differential diagnoses, before looking for positive arguments for the disease. Knowledge of normal and abnormal lachrymal and salivary gland physiology allows the clinician to prescribe the most adapted procedures for evaluating their function and structure. New tests have been developed in recent years for evaluating these patients, notably new ocular surface staining scores or salivary gland ultrasonography. We describe the different diagnoses performed in our monocentric cohort of 240 patients with suspected pSS. The most frequent diagnoses are pSS, other systemic autoimmune diseases, idiopathic sicca syndrome and drug-induced sicca syndrome. However, other diseases are important to rule out due to their specific management, such as sarcoidosis, granulomatosis with polyangeitis, IgG4-related disease, chronic hepatitis C virus or human immunodeficiency virus infections, graft-versus-host disease, and head and neck radiation therapy. At the light of these data, we propose a core of minimal investigations to be performed when evaluating a patient with suspected pSS.

Keywords

Sjögren’s syndrome Xerostomia Xerophtalmia Salivary gland swelling Diagnosis 

Abbreviations

AECG

American-European Consensus Group

BUT

Break-up time

GVHD

Graft-versus-host disease

HCV

Hepatitis C virus

HIV

Human immunodeficiency virus

OSS

Ocular staining score

pSS

Primary Sjögren’s syndrome

SGUS

Salivary gland ultrasonography

UWSF

Unstimulated whole salivary flow

Notes

Conflict of Interest

The authors have no conflict of interest to declare.

Fundings

None.

References

  1. 1.
    Fox RI (2005) Sjögren’s syndrome. Lancet 366:321–331CrossRefPubMedGoogle Scholar
  2. 2.
    Dupond J-L (2011) Fatigue in patients with rheumatic diseases. Jt Bone Spine Rev Rhum 78:156–160CrossRefGoogle Scholar
  3. 3.
    Youinou P, Devauchelle-Pensec V, Pers J-O (2010) Significance of B cells and B cell clonality in Sjögren’s syndrome. Arthritis Rheum 62:2605–2610CrossRefPubMedGoogle Scholar
  4. 4.
    Binard A, Devauchelle-Pensec V, Fautrel B, Jousse S, Youinou P, Saraux A (2007) Epidemiology of Sjögren’s syndrome: where are we now? Clin Exp Rheumatol 25:1–4PubMedGoogle Scholar
  5. 5.
    Vitali C, Bombardieri S, Jonsson R et al (2002) Classification criteria for Sjögren’s syndrome: a revised version of the European criteria proposed by the American-European Consensus Group. Ann Rheum Dis 61:554–558PubMedCentralCrossRefPubMedGoogle Scholar
  6. 6.
    Shiboski SC, Shiboski CH, Criswell LA et al (2012) American College of Rheumatology classification criteria for Sjögren’s syndrome: a data‐driven, expert consensus approach in the Sjögren’s International Collaborative Clinical Alliance Cohort. Arthritis Care Res 64:475–487CrossRefGoogle Scholar
  7. 7.
    Vitali C, Bootsma H, Bowman SJ et al (2013) Classification criteria for Sjogren’s syndrome: we actually need to definitively resolve the long debate on the issue. Ann Rheum Dis 72:476–478CrossRefPubMedGoogle Scholar
  8. 8.
    Rasmussen A, Ice JA, Li H et al (2014) Comparison of the American-European Consensus Group Sjögren’s syndrome classification criteria to newly proposed American College of Rheumatology criteria in a large, carefully characterised sicca cohort. Ann Rheum Dis 73:31–38CrossRefPubMedGoogle Scholar
  9. 9.
    Bowman SJ, Fox RI (2014) Classification criteria for Sjogren’s syndrome: nothing ever stands still! Ann Rheum Dis 73:1–2CrossRefPubMedGoogle Scholar
  10. 10.
    Cornec D, Saraux A, Cochener B et al (2014) Level of agreement between 2002 American–European Consensus Group and 2012 American College of Rheumatology classification criteria for Sjögren’s syndrome and reasons for discrepancies. Arthritis Res Ther 16:R74PubMedCentralCrossRefPubMedGoogle Scholar
  11. 11.
    Cornec D, Jamin C, Pers J-O (2014) Sjögren’s syndrome: where do we stand, and where shall we go? J Autoimmun 51:109–114CrossRefPubMedGoogle Scholar
  12. 12.
    Cornec D, Devauchelle-Pensec V, Tobón GJ, Pers J-O, Jousse-Joulin S, Saraux A (2012) B cells in Sjögren’s syndrome: from pathophysiology to diagnosis and treatment. J Autoimmun 39:161–167CrossRefPubMedGoogle Scholar
  13. 13.
    Berthelot J-M, Jamin C, Amrouche K, Le Goff B, Maugars Y, Youinou P (2013) Regulatory B cells play a key role in immune system balance. Jt Bone Spine 80:18–22CrossRefGoogle Scholar
  14. 14.
    Cornec D, Saraux A, Devauchelle-Pensec V, Clodic C, Pers J-O (2013) The future of B cell-targeted therapies in Sjögren’s syndrome. Immunotherapy 5:639–646CrossRefPubMedGoogle Scholar
  15. 15.
    Tobón GJ, Pers JO, Youinou P, Saraux A (2010) B cell-targeted therapies in Sjögren’s syndrome. Autoimmun Rev 9:224–228CrossRefPubMedGoogle Scholar
  16. 16.
    McCarty CA, Bansal AK, Livingston PM, Stanislavsky YL, Taylor HR (1998) The epidemiology of dry eye in Melbourne, Australia. Ophthalmology 105:1114–1119CrossRefPubMedGoogle Scholar
  17. 17.
    Lin P-Y, Tsai S-Y, Cheng C-Y, Liu J-H, Chou P, Hsu W-M (2003) Prevalence of dry eye among an elderly Chinese population in Taiwan: the Shihpai Eye Study. Ophthalmology 110:1096–1101CrossRefPubMedGoogle Scholar
  18. 18.
    Schaumberg DA, Sullivan DA, Buring JE, Dana MR (2003) Prevalence of dry eye syndrome among US women. Am J Ophthalmol 136:318–326CrossRefPubMedGoogle Scholar
  19. 19.
    Moss SE, Klein R, Klein BE (2000) Prevalence of and risk factors for dry eye syndrome. Arch Ophthalmol 118:1264–1268CrossRefPubMedGoogle Scholar
  20. 20.
    O’Brien PD, Collum LMT (2004) Dry eye: diagnosis and current treatment strategies. Curr Allergy Asthma Rep 4:314–319CrossRefPubMedGoogle Scholar
  21. 21.
    Orellana MF, Lagravère MO, Boychuk DGJ, Major PW, Flores-Mir C (2006) Prevalence of xerostomia in population-based samples: a systematic review. J Public Health Dent 66:152–158CrossRefPubMedGoogle Scholar
  22. 22.
    Ikebe K, Nokubi T, Sajima H et al (2001) Perception of dry mouth in a sample of community-dwelling older adults in Japan. Spec Care Dent Off Publ Am Assoc Hosp Dent Acad Dent Handicap Am Soc Geriatr Dent 21:52–59Google Scholar
  23. 23.
    Nederfors T, Isaksson R, Mörnstad H, Dahlöf C (1997) Prevalence of perceived symptoms of dry mouth in an adult Swedish population—relation to age, sex and pharmacotherapy. Community Dent Oral Epidemiol 25:211–216CrossRefPubMedGoogle Scholar
  24. 24.
    Billings RJ, Proskin HM, Moss ME (1996) Xerostomia and associated factors in a community-dwelling adult population. Community Dent Oral Epidemiol 24:312–316CrossRefPubMedGoogle Scholar
  25. 25.
    Pajukoski H, Meurman JH, Halonen P, Sulkava R (2001) Prevalence of subjective dry mouth and burning mouth in hospitalized elderly patients and outpatients in relation to saliva, medication, and systemic diseases. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 92:641–649CrossRefPubMedGoogle Scholar
  26. 26.
    Duquenne C, Cornec D, Pers J-O et al (2013) Current diagnostic tools for Sjögren’s syndrome. Int J Clin Rheumatol 8:281–290CrossRefGoogle Scholar
  27. 27.
    Van Bijsterveld OP (1969) Diagnostic tests in the Sicca syndrome. Arch Ophthalmol 82:10–14CrossRefPubMedGoogle Scholar
  28. 28.
    Whitcher JP, Shiboski CH, Shiboski SC et al (2010) A simplified quantitative method for assessing keratoconjunctivitis sicca from the Sjögren’s Syndrome International Registry. Am J Ophthalmol 149:405–415PubMedCentralCrossRefPubMedGoogle Scholar
  29. 29.
    Speight PM, Kaul A, Melsom RD (1992) Measurement of whole unstimulated salivary flow in the diagnosis of Sjögren’s syndrome. Ann Rheum Dis 51:499–502PubMedCentralCrossRefPubMedGoogle Scholar
  30. 30.
    Jorkjend L, Johansson A, Johansson A-K, Bergenholtz A (2004) Resting and stimulated whole salivary flow rates in Sjögren’s syndrome patients over time: a diagnostic aid for subsidized dental care? Acta Odontol Scand 62:264–268CrossRefPubMedGoogle Scholar
  31. 31.
    Bookman AAM, Shen H, Cook RJ et al (2011) Whole stimulated salivary flow: correlation with the pathology of inflammation and damage in minor salivary gland biopsy specimens from patients with primary Sjögren’s syndrome but not patients with sicca. Arthritis Rheum 63:2014–2020CrossRefPubMedGoogle Scholar
  32. 32.
    Pijpe J, van Imhoff GW, Spijkervet FKL et al (2005) Rituximab treatment in patients with primary Sjögren’s syndrome: an open-label phase II study. Arthritis Rheum 52:2740–2750CrossRefPubMedGoogle Scholar
  33. 33.
    Ramos-Casals M, Brito-Zerón P, Perez-DE-Lis M et al (2010) Clinical and prognostic significance of parotid scintigraphy in 405 patients with primary Sjogren’s syndrome. J Rheumatol 37:585–590CrossRefPubMedGoogle Scholar
  34. 34.
    Tonami H, Higashi K, Matoba M, Yokota H, Yamamoto I, Sugai S (2001) A comparative study between MR sialography and salivary gland scintigraphy in the diagnosis of Sjögren syndrome. J Comput Assist Tomogr 25:262–268CrossRefPubMedGoogle Scholar
  35. 35.
    Daniels TE, Benn DK (1996) Is sialography effective in diagnosing the salivary component of Sjögren’s syndrome? Adv Dent Res 10:25–28CrossRefPubMedGoogle Scholar
  36. 36.
    Cornec D, Jousse-Joulin S, Pers J-O et al (2013) Contribution of salivary gland ultrasonography to the diagnosis of Sjögren’s syndrome: toward new diagnostic criteria? Arthritis Rheum 65:216–225CrossRefPubMedGoogle Scholar
  37. 37.
    De Vita S, Lorenzon G, Rossi G, Sabella M, Fossaluzza V (1992) Salivary gland echography in primary and secondary Sjögren’s syndrome. Clin Exp Rheumatol 10:351–356PubMedGoogle Scholar
  38. 38.
    Cornec D, Jousse-Joulin S, Marhadour T et al (2014) Salivary gland ultrasonography improves the diagnostic performance of the 2012 American College of Rheumatology classification criteria for Sjögren’s syndrome. Rheumatology keu037Google Scholar
  39. 39.
    Daniels TE (1984) Labial salivary gland biopsy in Sjögren’s syndrome. Assessment as a diagnostic criterion in 362 suspected cases. Arthritis Rheum 27:147–156CrossRefPubMedGoogle Scholar
  40. 40.
    Chisholm DM, Mason DK (1968) Labial salivary gland biopsy in Sjögren’s disease. J Clin Pathol 21:656–660PubMedCentralCrossRefPubMedGoogle Scholar
  41. 41.
    Guellec D, Cornec D, Jousse-Joulin S et al (2013) Diagnostic value of labial minor salivary gland biopsy for Sjögren’s syndrome: a systematic review. Autoimmun Rev 12:416–420CrossRefPubMedGoogle Scholar
  42. 42.
    Pijpe J, Kalk WWI, van der Wal JE et al (2007) Parotid gland biopsy compared with labial biopsy in the diagnosis of patients with primary Sjögren’s syndrome. Rheumatology 46:335–341CrossRefPubMedGoogle Scholar
  43. 43.
    Pollard RPE, Pijpe J, Bootsma H et al (2011) Treatment of mucosa-associated lymphoid tissue lymphoma in Sjogren’s syndrome: a retrospective clinical study. J Rheumatol 38:2198–2208CrossRefPubMedGoogle Scholar
  44. 44.
    Doan S (2009) Atteinte oculaire et environnement : clinique et physiopathologie. Rev Fr Allergol 49:416–419CrossRefGoogle Scholar
  45. 45.
    Van Zuuren EJ, Kramer S, Carter B, Graber MA, Fedorowicz Z (2011) A Interventions for rosacea. Cochrane Database Syst Rev CD003262Google Scholar
  46. 46.
    Gilboe IM, Kvien TK, Uhlig T, Husby G (2001) Sicca symptoms and secondary Sjögren’s syndrome in systemic lupus erythematosus: comparison with rheumatoid arthritis and correlation with disease variables. Ann Rheum Dis 60:1103–1109PubMedCentralCrossRefPubMedGoogle Scholar
  47. 47.
    Avouac J, Sordet C, Depinay C et al (2006) Systemic sclerosis-associated Sjögren’s syndrome and relationship to the limited cutaneous subtype: results of a prospective study of sicca syndrome in 133 consecutive patients. Arthritis Rheum 54:2243–2249CrossRefPubMedGoogle Scholar
  48. 48.
    Brun JG, Madland TM, Jonsson R (2003) A prospective study of sicca symptoms in patients with rheumatoid arthritis. Arthritis Rheum 49:187–192CrossRefPubMedGoogle Scholar
  49. 49.
    Binard A, Le Pottier L, Devauchelle-Pensec V, Saraux A, Youinou P, Pers J-O (2009) Is the blood B-cell subset profile diagnostic for Sjogren syndrome? Ann Rheum Dis 68:1447–1452PubMedCentralCrossRefPubMedGoogle Scholar
  50. 50.
    Cornec D, Saraux A, Pers J-O et al (2014) Diagnostic accuracy of blood B-cell subset profiling and autoimmunity markers in Sjögren’s syndrome. Arthritis Res Ther 16:R15PubMedCentralCrossRefPubMedGoogle Scholar
  51. 51.
    Ramos-Casals M, Brito-Zerón P, García-Carrasco M, Font J (2004) Sarcoidosis or Sjögren syndrome? Clues to defining mimicry or coexistence in 59 cases. Medicine (Baltimore) 83:85–95CrossRefGoogle Scholar
  52. 52.
    Imanguli MM, Atkinson JC, Mitchell SA et al (2010) Salivary gland involvement in chronic graft-versus-host disease: prevalence, clinical significance, and recommendations for evaluation. Biol Blood Marrow Transplant 16:1362–1369PubMedCentralCrossRefPubMedGoogle Scholar
  53. 53.
    Guchelaar HJ, Vermes A, Meerwaldt JH (1997) Radiation-induced xerostomia: pathophysiology, clinical course and supportive treatment. Support Care Cancer Off J Multinatl Assoc Support Care Cancer 5:281–288Google Scholar
  54. 54.
    Ship JA, Hu K (2004) Radiotherapy-induced salivary dysfunction. Semin Oncol 31:29–36CrossRefPubMedGoogle Scholar
  55. 55.
    Eisbruch A, Ten Haken RK, Kim HM, Marsh LH, Ship JA (1999) Dose, volume, and function relationships in parotid salivary glands following conformal and intensity-modulated irradiation of head and neck cancer. Int J Radiat Oncol Biol Phys 45:577–587CrossRefPubMedGoogle Scholar
  56. 56.
    Vitali C (2011) Immunopathologic differences of Sjögren’s syndrome versus sicca syndrome in HCV and HIV infection. Arthritis Res Ther 13:233PubMedCentralCrossRefPubMedGoogle Scholar
  57. 57.
    Creuzot-Garcher C (2009) Ocular dryness related to systemic medications. J Fr Ophtalmol 32:64–70CrossRefPubMedGoogle Scholar
  58. 58.
    Moore PA, Guggenheimer J, Etzel KR, Weyant RJ, Orchard T (2001) Type 1 diabetes mellitus, xerostomia, and salivary flow rates. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 92:281–291CrossRefPubMedGoogle Scholar
  59. 59.
    Botsios C, Furlan A, Ostuni P et al (2011) Elderly onset of primary Sjögren’s syndrome: clinical manifestations, serological features and oral/ocular diagnostic tests. Comparison with adult and young onset of the disease in a cohort of 336 Italian patients. Jt Bone Spine Rev Rhum 78:171–174CrossRefGoogle Scholar
  60. 60.
    Versura P, Campos EC (2005) Menopause and dry eye. A possible relationship. Gynecol Endocrinol Off J Int Soc Gynecol Endocrinol 20:289–298CrossRefGoogle Scholar
  61. 61.
    Lemos-Júnior CA, Camargo A (2011) Images in clinical medicine. Sialolith of the submandibular salivary gland. N Engl J Med 364:551CrossRefPubMedGoogle Scholar
  62. 62.
    Dua A, Manadan A (2013) Heerfordt’s syndrome, or uveoparotid fever. N Engl J Med 369:458CrossRefPubMedGoogle Scholar
  63. 63.
    Takahashi H, Yamamoto M, Suzuki C, Naishiro Y, Shinomura Y, Imai K (2010) The birthday of a new syndrome: IgG4-related diseases constitute a clinical entity. Autoimmun Rev 9:591–594CrossRefPubMedGoogle Scholar
  64. 64.
    Palazzo E, Palazzo C, Palazzo M (2013) IgG4-related disease. Jt Bone Spine Rev RhumGoogle Scholar
  65. 65.
    Trimarchi M, Sinico RA, Teggi R, Bussi M, Specks U, Meroni PL (2013) Otorhinolaryngological manifestations in granulomatosis with polyangiitis (Wegener’s). Autoimmun Rev 12:501–505CrossRefPubMedGoogle Scholar
  66. 66.
    Kim D, Uy C, Mandel L (1998) Sialosis of unknown origin. N Y State Dent J 64:38–40PubMedGoogle Scholar
  67. 67.
    Romanos GE, Javed F, Romanos EB, Williams RC (2012) Oro-facial manifestations in patients with eating disorders. Appetite 59:499–504CrossRefPubMedGoogle Scholar

Copyright information

© Springer Science+Business Media New York 2014

Authors and Affiliations

  • Divi Cornec
    • 1
    • 2
    • 3
  • Alain Saraux
    • 1
    • 2
    • 3
  • Sandrine Jousse-Joulin
    • 1
    • 2
    • 3
  • Jacques-Olivier Pers
    • 2
    • 3
    • 4
  • Sylvie Boisramé-Gastrin
    • 4
  • Yves Renaudineau
    • 2
    • 3
    • 4
    • 5
  • Yves Gauvin
    • 6
  • Anne-Marie Roguedas-Contios
    • 7
  • Steeve Genestet
    • 8
  • Myriam Chastaing
    • 9
  • Béatrice Cochener
    • 10
  • Valérie Devauchelle-Pensec
    • 1
    • 2
    • 3
    • 11
  1. 1.Department of RheumatologyBrest Teaching HospitalBrestFrance
  2. 2.EA2216, INSERM ESPRI, ERI29Université de BrestBrestFrance
  3. 3.LabEx IGOBrestFrance
  4. 4.Department of OdontologyBrest Teaching HospitalBrestFrance
  5. 5.Laboratory of ImmunologyBrest Teaching HospitalBrestFrance
  6. 6.Department of Ear, Nose, ThroatBrest Teaching HospitalBrestFrance
  7. 7.Department of DermatologyBrest Teaching HospitalBrestFrance
  8. 8.Department of Neurological Functional ExplorationsBrest Teaching HospitalBrestFrance
  9. 9.Department of PsychiatryBrest Teaching HospitalBrestFrance
  10. 10.Department of OphthalmologyBrest Teaching HospitalBrestFrance
  11. 11.Service de RhumatologieHôpital de la Cavale BlancheBrest CedexFrance

Personalised recommendations